Research


Risk and Reward in the Orphan Drug Industry

with Richard Thakor, The Journal of Portfolio Management

View abstract

A Portfolio Approach to Accelerate Therapeutic Innovation in Ovarian Cancer

with Shomesh Chaudhuri, Katherine Cheng, Shirley Pepke, Sergio Rinaudo, Lynda Roman, and Ryan Spencer, The Journal of Investment Management

View abstract

Machine Learning with Statistical Imputation for Predicting Drug Approvals

with Kien Wei Siad and Chi Heem Wong, Harvard Data Science Review

View abstract

Acceleration of rare disease therapeutic development: a case study of AGIL-AADC

with Sonya Das, Samuel Huang, Drug Discovery Today

View abstract

Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design

with Leah Isakov and Vahid Montazerhodjat, Journal of Econometrics

View abstract

New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics A Review

with Sonya Das, Raphael Rousseau, Peter C. Adamson, JAMA Oncology

View abstract

Patient-centered clinical trials

with Shomesh E. Chaudhuri,  Martin P. Ho, Telba Irony, and Murray Sheldon, Drug Discovery Today Volume 23, Issue 2, February 2018, Pages 395-401

View abstract

Estimation of clinical trial success rates and related parameters

with Chi Heem Wong, Kien Wei Siah, Biostatistics (2018) 00, 00, pp. 1–14

View abstract

Pricing for Survival in the Biopharma Industry: A Case Study of Acthar Gel and Questcor Pharmaceuticals

with Terence C. Burnham and Samuel Huang, Journal of Investment Management

View abstract

Just how good an investment is the biopharmaceutical sector?

with Richard T Thakor, Nicholas Anaya, Yuwei Zhang, Christian Vilanilam, Kien Wei Siah, Chi Heem Wong, Nature Biotechnology

View abstract

Follow me on © 2019 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design